Notable Wednesday Option Activity: AVGO, GOOG, AMGN

Alphabet (GOOG) saw unusually heavy options activity with 184,641 contracts traded (≈18.5M underlying shares), representing ~87.1% of its one‑month average daily volume of 21.2M shares; the $335 put expiring March 20, 2026 traded 10,701 contracts (~1.1M shares). Amgen (AMGN) registered 24,308 contracts (≈2.4M underlying shares), ~85.1% of its one‑month average daily volume of 2.9M shares, led by 2,402 contracts in the $295 call expiring February 20, 2026 (~240.2K shares). The scale and concentration of activity suggest sizable directional bets or hedging flows but the report is descriptive market flow data rather than new fundamental company information.

Analysis

Market structure: The huge GOOG put flow (10,701 contracts, ~1.1M shares at $335 Mar-20-2026) versus AMGN call flow (2,402 contracts, ~240k shares Feb-20-2026) implies asymmetric directional hedging: dealers selling into GOOG to delta-hedge puts and buying AMGN into call hedges, creating near-term downward pressure on GOOG and upward pressure on AMGN. Because the GOOG flow equals ~87% of average daily volume in option-equivalent shares, order-book liquidity could be transiently thin around key strikes, amplifying moves and IV skew; market-makers’ gamma exposure concentrated at $335 creates pin/volatility risk around March expiry. Cross-asset: a spike in equity vol from tech selling could push Treasury bid (lower yields) and USD safe-haven flows, while pharma defensive flows could tighten IG spreads modestly.

Risk assessment: Tail risks include regulatory shocks for GOOG (antitrust fines or advertising revenue shock) and trial/patent setbacks for AMGN; either could move the respective stock >20% within months. Immediate (days) risk is dealer hedging-driven price swings; short-term (weeks–months) risk is IV re-pricing and position unwinds; long-term (quarters) fundamentals—ad spend recovery or drug approvals—matter. Hidden dependencies: one large institutional hedge could be creating synthetic short exposure elsewhere (index derivatives), and gamma clustering near $335 may force exaggerated moves if price approaches that strike. Catalysts: GOOG ad/revenue updates, AMGN clinical/regulatory news, and Fed/CPI data that shift equity beta.

Trade implications: For GOOG favor protective, limited-risk bearish structures rather than naked short stock—e.g., buy Mar-2026 $335–$300 put spreads sized to 1–2% of portfolio to cap cost while benefiting from dealer selling; avoid large-duration naked put shorts while IV is elevated. For AMGN consider buying Feb-2026 $295 call spreads or 1–1.5% outright long stock exposure funded by trimming cyclical tech; implement within 10 trading days while flow persists and scale out through Feb earnings or options expiry. Pair trade: long AMGN / short GOOG equal-dollar (0.5–1% each) to express defensive rotation and capture dispersion if flows continue.

Key Decisions for Investors

• Establish a 1–2% portfolio position: buy GOOG Mar-20-2026 $335–$300 put spread (debit) to hedge downside through March expiry; cap max loss to spread cost and target 2–4x payoff if GOOG drops >7–12% from current levels. Execute within 7–10 trading days while put-flow persists.
• Initiate a 1–1.5% long position in AMGN via Feb-20-2026 $295–$325 call spread (debit) or buy 1% stock outright funded by trimming cyclical tech exposure; target holding through Feb earnings/clinical readouts and take profits at +15–25% or on IV collapse >20% from today’s level.
• Pair trade: implement equal-dollar long AMGN / short GOOG net 0.5–1% positions to express defensive rotation; monitor intraday delta—if GOOG IV rises >20% vs 60-day average, convert short GOOG leg into a delta-neutral collar to limit gamma risk.
• Volatility play: if GOOG 1-month IV >30% above its 60-day average, sell a calendar or diagonal spread (sell near-dated calls or puts, buy further-dated) to capture overstated short-term premium; limit size to 0.5–1% and exit when IV compresses by 15–20% or within 30 days.